Portable hemoglobinometer is a reliable technology for the follow-up of venesections tolerance in hemochromatosis - 01/10/15
, Edouard Bardou-Jacquet b, c, Marianne Latournerie c, Selim Zerrouki c, Claude Bendavid a, Pierre Brissot b, c, Martine Ropert a, cBenvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
| pagine | 6 |
| Iconografia | 3 |
| Video | 0 |
| Altro | 0 |
Summary |
Background |
The treatment of HFE-related hemochromatosis, one of the most common genetic diseases, is based on phlebotomies whose tolerance is evaluated by regular monitoring of hemoglobin. Using a portable hemoglobinometer (PH) could provide an easy and fast determination of hemoglobin. Therefore, the aim of the present study was to compare, in hemochromatosis patients treated by bloodletting, the hemoglobin concentrations as assayed, on capillary blood, by a PH device and, on venous blood, by a cell counter (CC) device.
Methods |
For a total period of 12 weeks duration, all patients undergoing phlebotomies in the same hospital outpatient unit had hemoglobin determinations both by the HemoCue and by the laboratory's DxH 800 Coulter. To evaluate the sensitivity and specificity of the HemoCue, patients were classified as presenting or not anemia as defined by hemoglobin level below 11g/dl.
Results |
Measurements of hemoglobin were performed in 122 patients. The sensitivity and specificity of PH compared to CC were 100 and 98.1%, respectively. Capillary hemoglobin by PH slightly underestimated venous hemoglobin by CC. The Pearson's correlation coefficient between PH and CC was 0.80 (P<0.0001).
Conclusion |
PH is a reliable, quick and easy technology, which can be proposed to follow-up the tolerance of venesections in hemochromatosis patients.
Il testo completo di questo articolo è disponibile in PDF.Mappa
Vol 39 - N° 5
P. 570-575 - ottobre 2015 Ritorno al numero
Articolo precedente
- Immune dysregulation in Alagille syndrome: A new feature of the evolving phenotype
- S. Tilib Shamoun, G. Le Friec, N. Spinner, C. Kemper, A.J. Baker
- IL28B rs12980275 variant as a predictor of sustained virologic response to pegylated-interferon and ribavirin in chronic hepatitis C patients: A systematic review and meta-analysis
- Hao Zheng, Man Li, Bing Chi, Xiao-xue Wu, Jia Wang, Dian-Wu Liu
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?